These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22613268)

  • 1. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
    Zhang L; Jin H; Guo X; Yang Z; Zhao L; Tang S; Mo P; Wu K; Nie Y; Pan Y; Fan D
    Clin Biochem; 2012 Sep; 45(13-14):1064-9. PubMed ID: 22613268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.
    Sun L; Hu W; Liu Q; Hao Q; Sun B; Zhang Q; Mao S; Qiao J; Yan X
    J Proteome Res; 2012 May; 11(5):2937-46. PubMed ID: 22428626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel serum metabolomics-based diagnostic approach to pancreatic cancer.
    Kobayashi T; Nishiumi S; Ikeda A; Yoshie T; Sakai A; Matsubara A; Izumi Y; Tsumura H; Tsuda M; Nishisaki H; Hayashi N; Kawano S; Fujiwara Y; Minami H; Takenawa T; Azuma T; Yoshida M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):571-9. PubMed ID: 23542803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture.
    Wu Q; Zhang Q; Sun B; Yan X; Tang Y; Qiao X; Chen Q; Yu S; Liang F
    J Pharm Biomed Anal; 2010 Feb; 51(3):698-704. PubMed ID: 19854601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis.
    OuYang D; Xu J; Huang H; Chen Z
    Appl Biochem Biotechnol; 2011 Sep; 165(1):148-54. PubMed ID: 21505807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
    Ouyang X; Dai Y; Wen JL; Wang LX
    Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of nuclear magnetic resonance spectroscopy for pancreatic cancer studies.
    Tesiram YA; Lerner M; Stewart C; Njoku C; Brackett DJ
    Pancreas; 2012 Apr; 41(3):474-80. PubMed ID: 22422139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic characterization of human pancreatitis by ¹H-NMR spectroscopy.
    Ouyang D
    Hepatogastroenterology; 2012 Oct; 59(119):2314-7. PubMed ID: 22328301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids.
    Feng J; Liu H; Zhang L; Bhakoo K; Lu L
    Nanotechnology; 2010 Oct; 21(39):395101. PubMed ID: 20820093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol metabolism is modulated by quercetin in rats.
    Zhao L; Wu J; Wang Y; Yang J; Wei J; Gao W; Guo C
    J Agric Food Chem; 2011 Feb; 59(4):1104-8. PubMed ID: 21250691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
    Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma.
    Rocha CM; Carrola J; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
    J Proteome Res; 2011 Sep; 10(9):4314-24. PubMed ID: 21744875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of pancreatic cancer via
    Michálková L; Horník Š; Sýkora J; Habartová L; Setnička V
    Analyst; 2018 Dec; 143(24):5974-5978. PubMed ID: 30270368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
    Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
    J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
    Chang MC; Chang YT; Su TC; Yang WS; Chen CL; Tien YW; Liang PC; Wei SC; Wong JM
    Pancreas; 2007 Jul; 35(1):16-21. PubMed ID: 17575540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
    Park JK; Ryu JK; Yoon WJ; Lee SH; Lee GY; Jeong KS; Kim YT; Yoon YB
    Pancreas; 2012 Jan; 41(1):95-101. PubMed ID: 21778928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance.
    Hyötyläinen T; Mattila I; Wiedmer SK; Koivuniemi A; Taskinen MR; Yki-Järvinen H; Orešič M
    Mol Biosyst; 2012 Oct; 8(10):2559-65. PubMed ID: 22722885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular angiogenesis profile as a tool to discriminate chronic pancreatitis (CP) from pancreatic cancer (PC).
    Berindan-Neagoe I; Burz C; Balacescu O; Balacescu L; Seicean A; Cristea V; Irimie A
    Pancreas; 2011 Apr; 40(3):482-3. PubMed ID: 21412121
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabonomic variation of esophageal cancer within different ethnic groups in Xinjiang, China].
    Ayxiam H; Ma H; Ilyar S; Zhang LW; Ablizi A; Batur M; Lu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):591-6. PubMed ID: 19954070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.